Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec

NCT07658417 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin icodec

Sponsor

Novo Nordisk A/S